| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/20/2011 | EP2345410A1 Controlled release pharmaceutical composition |
| 07/20/2011 | EP2344519A2 C-terminal fragments of glucagon-like peptide-1 (glp-1) |
| 07/20/2011 | EP2344503A2 5-azaindole bisphosphonates |
| 07/20/2011 | EP2344501A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators |
| 07/20/2011 | EP2344493A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/20/2011 | EP2344492A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/20/2011 | EP2344475A1 Quinazolinone, quinolone and related analogs as sirtuin modulators |
| 07/20/2011 | EP2344471A1 7-piperidinoalkyl-3,4-dihydroquinolone derivative |
| 07/20/2011 | EP2344465A1 Crystalline forms of (r) -5- [3-chloro-4-( 2, 3-dihydroxy-propoxy)-benz [z]ylidene]-2- [z]-propylimino) -3-0-tolyl-thiazolidin-4-one |
| 07/20/2011 | EP2344459A1 2,3-substituted indazole or 4,5,6,7-tetrahydro-indazoles as fxr modulators against dyslipidemia and related diseases |
| 07/20/2011 | EP2344458A1 Heteroaryls amide derivatives and their use as glucokinase activators |
| 07/20/2011 | EP2344195A2 Combination therapy for the treatment of diabetes and related conditions |
| 07/20/2011 | EP2344194A2 Pcsk9 antagonists |
| 07/20/2011 | EP2344154A1 Compositions that include anthocyanidins and methods of use |
| 07/20/2011 | EP2114935B1 Piperidine gpcr agonists |
| 07/20/2011 | EP2049544B9 Purinone derivatives as hm74a agonists |
| 07/20/2011 | EP1833847B1 Igf-1 fusion polypeptides and therapeutic uses thereof |
| 07/20/2011 | EP1482920B2 Compositions containing n-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 07/20/2011 | EP1157043B1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 07/20/2011 | CN1978466B Transduction peptide-human brain-derived neurotrophic factor fusion protein and its use |
| 07/20/2011 | CN1951965B Glp-1衍生物 Glp-1 derivatives |
| 07/20/2011 | CN1944448B Puerarin derivative and its medicinal use |
| 07/20/2011 | CN1930137B Novel benzothiazepine and benzothiepine compounds |
| 07/20/2011 | CN1890228B Alpha-amino acid derivatives and use thereof as medicines |
| 07/20/2011 | CN1872184B Drop pills of reducing blood fat and preparation method |
| 07/20/2011 | CN102131806A Triazolopyridine compounds useful as kinase inhibitors |
| 07/20/2011 | CN102131798A Di-substituted phenyl compounds used as inhibitors of phosphodiesterase 10 |
| 07/20/2011 | CN102131778A Heterocyclic gpcr agonists |
| 07/20/2011 | CN102131504A Combinations comprising bicyclic S1P lyase inhibitors |
| 07/20/2011 | CN102127080A Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines |
| 07/20/2011 | CN102127072A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127071A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127070A Pyridine cyclo-derivative |
| 07/20/2011 | CN102127062A Substituted isoandrographolide derivative, preparation method and medical application thereof |
| 07/20/2011 | CN102127057A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102127053A Dipeptidyl peptidase inhibitors |
| 07/20/2011 | CN102125692A Wrapping agent in levo-carnitine wrapping technology and composition of ten series products and preparation method |
| 07/20/2011 | CN102125619A Chinese medicinal compound for adjunctively reducing blood sugar |
| 07/20/2011 | CN102125601A Method for analyzing gaoxing capsules by using fingerprint spectrum |
| 07/20/2011 | CN102125600A Chinese medicinal composition and preparation method thereof |
| 07/20/2011 | CN102125597A Sugar-free syrup for inhibiting appetite, cleaning intestinal tract and expelling toxin and preparation method thereof |
| 07/20/2011 | CN102125582A Silicon lattice active crystals |
| 07/20/2011 | CN102125581A Method for preparing vitamin D calcium soft capsules |
| 07/20/2011 | CN102125566A Pharmaceutical composition comprising cycloartenyl ferulate |
| 07/20/2011 | CN102125564A Novel application of ginsenoside PT in treating diabetes and metabolic syndrome |
| 07/20/2011 | CN102125560A Uses of DPP-IV inhibitors |
| 07/20/2011 | CN102125555A Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 07/20/2011 | CN102125544A Inducer for activating expression of fish lipid metabolism control gene and application thereof |
| 07/20/2011 | CN102125520A Emulsion containing hydrophilic biological macromolecule, preparation method and application thereof |
| 07/20/2011 | CN102125143A Diabetes food therapy recovery tea |
| 07/20/2011 | CN102125127A Functional highland barley red yeast rice tea and preparation method thereof |
| 07/20/2011 | CN102125125A Chinese medicinal weight-reducing healthy tea |
| 07/20/2011 | CN101850054B Chinese medicament for treating diabetic heart diseases |
| 07/20/2011 | CN101850049B Chinese medicament for treating diabetic foot |
| 07/20/2011 | CN101843878B Chinese medicament for treating diabetic cardiopathy |
| 07/20/2011 | CN101843870B Chinese medicament for treating diabetic acro-necrosis |
| 07/20/2011 | CN101837032B Blueberry anthocyanin oral solution |
| 07/20/2011 | CN101804110B Traditional Chinese medicine preparation for thrombosis and blood lipid |
| 07/20/2011 | CN101797341B Chinese herbal medicine pill capable of clearing blood fat and lowering blood pressure |
| 07/20/2011 | CN101787007B Dimeric sesquiterpene compound and applications thereof |
| 07/20/2011 | CN101732261B Stable type compound pellet, preparation method thereof and capsule containing same |
| 07/20/2011 | CN101721414B Composition containing pioglitazone hydrochloride and metformin hydrochloride and preparation thereof |
| 07/20/2011 | CN101703684B Medicament for treating allergic purpura and preparation method thereof |
| 07/20/2011 | CN101690789B Chinese medicinal preparation for treating diabetes |
| 07/20/2011 | CN101664397B Application of high-purity EPA-E and DHA polyenoic acid ethyl ester in preparation of nutritional supplement for patients in operative period |
| 07/20/2011 | CN101658528B Application of corn silk polysaccharide on preparation of medicine for curing hyperlipidemia |
| 07/20/2011 | CN101637484B Active extract for sanwei sandalwood as well as extraction method and medical application thereof |
| 07/20/2011 | CN101629146B Zinc-rich yeast with high biomass, breeding selection method and application thereof |
| 07/20/2011 | CN101559058B Pharmaceutical composition for treating dyslipidemia |
| 07/20/2011 | CN101530429B New use of clarias lazera |
| 07/20/2011 | CN101480404B Medicinal product of oryzanol and preparation method thereof |
| 07/20/2011 | CN101411785B Lotus and hawthorn tea drink for reducing blood fat |
| 07/20/2011 | CN101406232B Fat-eliminating antihypelipidemic health tea |
| 07/20/2011 | CN101401809B Preparation for composition of vitamin and mineral matter |
| 07/20/2011 | CN101396470B Traditional Chinese medicine for treating diabetic impotence |
| 07/20/2011 | CN101370779B Cyclohexyl sulfonamide derivatives having H3 receptor activity |
| 07/20/2011 | CN101301402B Nutrition health care replenisher for reinforcing reproduction performance of boar |
| 07/20/2011 | CN101297669B Chitosan oral scented pieces and preparation thereof |
| 07/20/2011 | CN101224256B Antidiabetics compounds of Chinese and western materia medica and preparing method thereof |
| 07/20/2011 | CN101199605B Detection method of Chinese medicine granules for treating diabetes |
| 07/20/2011 | CN101199603B Chinese medicine agent for treating diabetes |
| 07/20/2011 | CN101167861B Hypoglycemic compound traditional Chinese medicine liquid preparation and preparation method thereof |
| 07/20/2011 | CN101167526B Health product for dog and cat with growth promoting function |
| 07/20/2011 | CN101164566B Peony leaves total glycoside extract, its preparation method and application |
| 07/20/2011 | CN101152246B Pharmaceutical composition for cardiovascular and cerebrovascular diseases and method for preparing the same |
| 07/20/2011 | CN101069535B Jinyangye green tea and its making method |
| 07/19/2011 | US7982066 High protein supplement |
| 07/19/2011 | US7982049 α-form or β-form crystal of acetanilide derivative |
| 07/19/2011 | US7982048 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7981894 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/19/2011 | US7981873 Use within transplantation surgery |
| 07/19/2011 | US7981867 Use of des-aspartate-angiotensin I |
| 07/19/2011 | US7981861 Method of performing angioplasty with a GLP-1 molecule |
| 07/19/2011 | US7981631 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment and monitoring of periodontal diseases |
| 07/19/2011 | US7981419 Method for treating hypophosphatemic bone diseases using FGF-23 antibody |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | CA2485503C Phenyl-thiophene type vitamin d receptor modulators |
| 07/19/2011 | CA2472713C N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/19/2011 | CA2467046C Process for the manufacture of human mononuclear phagocytic leukocytes |